Selecting neuromuscular-blocking drugs for elderly patients

Area of Science:

• Anesthesiology
• Pharmacology
• Geriatrics

Background:

• Physiological changes with aging impact drug pharmacokinetics.
• Age-related declines in organ function affect drug clearance and elimination.
• Neuromuscular-blocking drugs' effects can be altered in elderly individuals.

Purpose of the Study:

• To review the effects of aging on the pharmacokinetics of neuromuscular-blocking drugs.
• To identify which neuromuscular-blocking drugs are most suitable for elderly patients.
• To provide guidance on safe use and monitoring of these drugs in older adults.

Main Methods:

• Review of existing literature on aging and neuromuscular-blocking drug pharmacokinetics.
• Analysis of drug properties, including elimination pathways (organ-dependent vs. independent).
• Comparison of clinical effects and safety profiles of various neuromuscular-blocking agents in the elderly.

Main Results:

• Organ-dependent neuromuscular-blocking drugs may have prolonged action in the elderly, necessitating dose adjustments and monitoring.
• Atracurium besilate and cisatracurium besilate, with organ-independent elimination, show less altered clinical duration of action.
• Cisatracurium besilate is highlighted as particularly suitable due to minimal cardiovascular effects.

Conclusions:

• Elderly patients exhibit altered pharmacokinetics for certain neuromuscular-blocking drugs, requiring careful management.
• Drugs with organ-independent elimination, like cisatracurium besilate, are preferable for older patients.
• Awareness of altered pharmacokinetics and vigilant monitoring are crucial for safe use of neuromuscular-blocking drugs in the elderly.